These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 14989743)
1. Immunohistopathological and molecular genetic features of a case in which gastrointestinal stromal tumor recurred five times. Inoue T; Suzuki T; Nakagawa K; Kurokawa Y; Satomi S; Moriya T; Sasano N; Sasano H Pathol Int; 2004 Mar; 54(3):196-200. PubMed ID: 14989743 [TBL] [Abstract][Full Text] [Related]
3. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach. Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
5. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens. Willmore-Payne C; Layfield LJ; Holden JA Cancer; 2005 Jun; 105(3):165-70. PubMed ID: 15822120 [TBL] [Abstract][Full Text] [Related]
6. Multiple gastrointestinal stromal tumors with a germline c-kit mutation. Kim HJ; Lim SJ; Park K; Yuh YJ; Jang SJ; Choi J Pathol Int; 2005 Oct; 55(10):655-9. PubMed ID: 16185297 [TBL] [Abstract][Full Text] [Related]
7. Malignant potential of gastrointestinal stromal tumor of the stomach. Aoyagi K; Kouhuji K; Yano S; Miyagi M; Imaizumi T; Takeda J; Shirouzu K Int Surg; 2009; 94(1):1-9. PubMed ID: 20099418 [TBL] [Abstract][Full Text] [Related]
8. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining. Lee HE; Kim MA; Lee HS; Lee BL; Kim WH J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383 [TBL] [Abstract][Full Text] [Related]
10. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). Martín J; Poveda A; Llombart-Bosch A; Ramos R; López-Guerrero JA; García del Muro J; Maurel J; Calabuig S; Gutierrez A; González de Sande JL; Martínez J; De Juan A; Laínez N; Losa F; Alija V; Escudero P; Casado A; García P; Blanco R; Buesa JM; J Clin Oncol; 2005 Sep; 23(25):6190-8. PubMed ID: 16135486 [TBL] [Abstract][Full Text] [Related]
13. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Agaimy A; Wünsch PH; Hofstaedter F; Blaszyk H; Rümmele P; Gaumann A; Dietmaier W; Hartmann A Am J Surg Pathol; 2007 Jan; 31(1):113-20. PubMed ID: 17197927 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications of C-kit gene mutation in patients with large gastrointestinal stromal tumors. Lin SC; Liu CL; Wang TI; Chang WS; Tzen CY; Huang MJ J Gastroenterol Hepatol; 2006 Oct; 21(10):1604-8. PubMed ID: 16928224 [TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal stromal tumors: usefulness of immunohistochemistry, flow cytometry and fluorescence in situ hybridization. Fontana MG; Rossi E; Bassotti G; Aquilano MC; Cadei M; Grigolato P; Villanacci V J Gastroenterol Hepatol; 2007 Nov; 22(11):1754-9. PubMed ID: 17914946 [TBL] [Abstract][Full Text] [Related]
16. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors. Can B; Sökmensüer C Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191 [TBL] [Abstract][Full Text] [Related]
19. Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients. Kang DY; Park CK; Choi JS; Jin SY; Kim HJ; Joo M; Kang MS; Moon WS; Yun KJ; Yu ES; Kang H; Kim KM Am J Surg Pathol; 2007 Feb; 31(2):224-32. PubMed ID: 17255767 [TBL] [Abstract][Full Text] [Related]
20. [Expression and mutation of c-kit gene in gastrointestinal stromal tumor]. Ma D; Liu X; Cai Z; Xie Q Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):461-4. PubMed ID: 12485499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]